Next Article in Journal
Safety, Tolerability, and Immunogenicity of a Recombinant Nonavalent Human Papillomavirus Vaccine (Escherichia coli) in Healthy Chinese Women Aged 18–45 Years: A Phase 1 Clinical Trial
Previous Article in Journal
Vaccine Research Trends in Africa from 2016 to Mid-2024: A Bibliometric Analysis
Previous Article in Special Issue
Immunogenicity Evaluation of Combination Respiratory Syncytial Virus and Varicella–Zoster Virus mRNA Vaccines in C57BL/6J Mice
 
 
Review

Article Versions Notes

Vaccines 2025, 13(5), 510; https://doi.org/10.3390/vaccines13050510
Action Date Notes Link
article xml file uploaded 12 May 2025 16:27 CEST Original file -
article xml uploaded. 12 May 2025 16:27 CEST Update https://www.mdpi.com/2076-393X/13/5/510/xml
article pdf uploaded. 12 May 2025 16:27 CEST Version of Record https://www.mdpi.com/2076-393X/13/5/510/pdf
article supplementary file uploaded. 12 May 2025 16:27 CEST - https://www.mdpi.com/2076-393X/13/5/510#supplementary
article html file updated 12 May 2025 16:29 CEST Original file https://www.mdpi.com/2076-393X/13/5/510/html
Back to TopTop